Pfizer Inc (PFE) - Financial and Strategic SWOT Analysis Review
Section 1 - About the Company
Pfizer Inc - Key Facts
Pfizer Inc - Key Employees
Pfizer Inc - Key Employee Biographies
Pfizer Inc - Major Products and Services
Pfizer Inc - History
Pfizer Inc - Company Statement
Pfizer Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Affiliate
Joint Venture
Section 2 – Company Analysis
Company Overview
Pfizer Inc - Business Description
Business Segment: Biopharma
Overview
Performance
Business Segment: Business Innovation
Overview
Performance
Geographical Segment: Developed Europe
Target Markets
Performance
Geographical Segment: Developed Rest of World
Target Markets
Performance
Geographical Segment: Emerging Markets
Target Markets
Performance
Geographical Segment: United States
Performance
R&D Overview
Pfizer Inc - Corporate Strategy
Pfizer Inc - SWOT Analysis
SWOT Analysis - Overview
Pfizer Inc - Strengths
Pfizer Inc - Weaknesses
Pfizer Inc - Opportunities
Pfizer Inc - Threats
Pfizer Inc - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Pfizer Inc, Pharmaceuticals & Healthcare, Deals By Year, 2018 to YTD 2024
Pfizer Inc, Pharmaceuticals & Healthcare, Deals By Type, 2018 to YTD 2024
Pfizer Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Oct 30, 2024: Pfizer boasts over 30% increase in Q3 revenues against previous year
Oct 22, 2024: Pfizer Supplies One Billionth Pneumococcal Conjugated Vaccine Dose for Vaccination of Children in Lower- Income Countries through Gavi, the Vaccine Alliance
Oct 18, 2024: Targeted Therapy, Driven by Comprehensive Genomic Profiling and Molecular Tumour Board, Improves Outcomes In Pretreated Patients with Metastatic Cancer
Oct 15, 2024: Pfizer Elects Mortimer Buckley to Board of Directors
Oct 08, 2024: Pfizer to Showcase Scientific Advancements in Respiratory and Other Infectious Diseases at IDWeek 2024
Sep 11, 2024: Pfizer Highlights Diverse Oncology Portfolio and Combination Approaches at ESMO 2024
Sep 05, 2024: Pfizer Appoints Elif Aral as Regional President for the Middle East, Russia & Africa
Aug 30, 2024: Albertsons Companies Pharmacies Announce COVID and Flu Vaccines Available Now to Help Protect Communities Against the Upcoming Respiratory Virus Season
Aug 27, 2024: Pfizer Launches PfizerForAll, a Digital Platform that Helps Simplify Access to Healthcare
Aug 22, 2024: FDA Approves and Authorizes Updated mRNA COVID-19 Vaccines to Better Protect Against Currently Circulating Variants
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
List of Tables
Pfizer Inc, Key Facts
Pfizer Inc, Key Employees
Pfizer Inc, Key Employee Biographies
Pfizer Inc, Major Products and Services
Pfizer Inc, History
Pfizer Inc, Subsidiaries
Pfizer Inc, Affiliate
Pfizer Inc, Joint Venture
Pfizer Inc, Key Competitors
Pfizer Inc, Ratios based on current share price
Pfizer Inc, Annual Ratios
Pfizer Inc, Annual Ratios (Cont...1)
Pfizer Inc, Annual Ratios (Cont...2)
Pfizer Inc, Interim Ratios
Pfizer Inc, Pharmaceuticals & Healthcare, Deals By Year, 2018 to YTD 2024
Pfizer Inc, Pharmaceuticals & Healthcare, Deals By Type, 2018 to YTD 2024
Pfizer Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
List of Figures
Pfizer Inc, Performance Chart (2019 - 2023)
Pfizer Inc, Ratio Charts
Pfizer Inc, Pharmaceuticals & Healthcare, Deals By Year, 2018 to YTD 2024
Pfizer Inc, Pharmaceuticals & Healthcare, Deals by Type, 2018 to YTD 2024